Trius Therapeutics, Inc. (TSRX): Are Hedge Funds Right About This Stock?

Page 1 of 2

Trius Therapeutics, Inc. (NASDAQ:TSRX) was in 8 hedge funds’ portfolio at the end of December. TSRX has experienced a decrease in enthusiasm from smart money recently. There were 11 hedge funds in our database with TSRX positions at the end of the previous quarter.

Trius Therapeutics, Inc. (NASDAQ:TSRX)If you’d ask most traders, hedge funds are assumed to be underperforming, old investment tools of the past. While there are greater than 8000 funds trading at the moment, we choose to focus on the upper echelon of this group, around 450 funds. It is estimated that this group oversees the majority of the hedge fund industry’s total capital, and by keeping an eye on their best picks, we have unearthed a few investment strategies that have historically beaten the broader indices. Our small-cap hedge fund strategy outperformed the S&P 500 index by 18 percentage points annually for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have outpaced the S&P 500 index by 24 percentage points in 7 months (see the details here).

Equally as key, optimistic insider trading activity is another way to break down the investments you’re interested in. There are many stimuli for a corporate insider to drop shares of his or her company, but only one, very obvious reason why they would buy. Various empirical studies have demonstrated the impressive potential of this strategy if shareholders understand where to look (learn more here).

With these “truths” under our belt, let’s take a glance at the recent action regarding Trius Therapeutics, Inc. (NASDAQ:TSRX).

What does the smart money think about Trius Therapeutics, Inc. (NASDAQ:TSRX)?

At the end of the fourth quarter, a total of 8 of the hedge funds we track held long positions in this stock, a change of -27% from the previous quarter. With hedgies’ sentiment swirling, there exists a select group of notable hedge fund managers who were boosting their holdings substantially.

Of the funds we track, Broadfin Capital, managed by Kevin Kotler, holds the largest position in Trius Therapeutics, Inc. (NASDAQ:TSRX). Broadfin Capital has a $5.8 million position in the stock, comprising 1.4% of its 13F portfolio. The second largest stake is held by Jean-Marie Eveillard of First Eagle Investment Management, with a $5.1 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Other peers that are bullish include Gregory Fraser, Rudolph Kluiber, and Timothy Kroch’s GRT Capital Partners, Brian Ashford-Russell and Tim Woolley’s Polar Capital and Israel Englander’s Millennium Management.

Since Trius Therapeutics, Inc. (NASDAQ:TSRX) has faced bearish sentiment from the smart money, it’s safe to say that there exists a select few money managers who sold off their entire stakes heading into 2013. At the top of the heap, JΘr⌠me Pfund and Michael Sj÷str÷m’s Sectoral Asset Management dumped the biggest investment of all the hedgies we monitor, worth close to $5.9 million in stock.. Richard Schimel’s fund, Diamondback Capital, also said goodbye to its stock, about $1.2 million worth. These moves are interesting, as aggregate hedge fund interest dropped by 3 funds heading into 2013.

Insider trading activity in Trius Therapeutics, Inc. (NASDAQ:TSRX)

Bullish insider trading is best served when the company in question has seen transactions within the past half-year. Over the last six-month time frame, Trius Therapeutics, Inc. (NASDAQ:TSRX) has experienced zero unique insiders buying, and 1 insider sales (see the details of insider trades here).

Let’s also examine hedge fund and insider activity in other stocks similar to Trius Therapeutics, Inc. (NASDAQ:TSRX). These stocks are NeoGenomics, Inc. (NASDAQ:NEO), TearLab Corporation (NASDAQ:TEAR), China Cord Blood Corp (NYSE:CO), Nordion Inc (USA) (NYSE:NDZ), and Novadaq Technologies Inc. (NASDAQ:NVDQ). This group of stocks are in the medical laboratories & research industry and their market caps are similar to TSRX’s market cap.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

6 Ways to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

The 10 Most Controversial Songs Of All Time to Hit (and get Banned from) the Airwaves

The 20 Biggest IPOs in US History

The 10 Best Places to Visit in Mexico that Are Beautiful and Safe

7 Bad Habits that Age You Beyond Your Years

The 40 Best Fortune Cookie Sayings That Will Leave You Bemused, Befuddled, or Beguiled

10 Foods to Eat Before a Workout to Make Every Drop of Sweat Count

The 5 Best Documentaries On Netflix You Must See

The Most Heartwarming and Inspirational Story Of This Halloween Season, It Will Make You Cry and Jump For Joy

10 Best Party Songs of All Time to Bring the House Down With

5 New World Order Conspiracy Theories that Will Strangle the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!